{"count": 2, "results": [{"_id": "18791746", "pmid": 18791746, "pmcid": "PMC7811526", "title": "Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats", "journal": "Pediatr Nephrol", "authors": ["Zhang W", "Li Q", "Wang L", "Yang X"], "date": "2008-12-01T00:00:00Z", "doi": "10.1007/s00467-008-0933-8", "meta_date_publication": "2008 Dec", "meta_volume": "23", "meta_issue": "12", "meta_pages": "2185-94", "score": 50102.625, "text_hl": "Male Sprague-Dawley @SPECIES_10116 @@@rats@@@ were randomly divided into control, @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@ADR@@@ @<m>DISEASE_Nephrosis</m> @DISEASE_MESH:D009401 @@@nephrosis@@@, and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-treated @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@ADR@@@ @<m>DISEASE_Nephrosis</m> @DISEASE_MESH:D009401 @@@nephrosis@@@ groups. ", "citations": {"NLM": "Zhang W, Li Q, Wang L, Yang X. Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats Pediatr Nephrol. 2008 Dec;23(12):2185-94. PMID: 18791746", "BibTeX": "@article{18791746, title={Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats}, author={Zhang W and Li Q and Wang L and Yang X}, journal={Pediatr Nephrol}, volume={23}, number={12}, pages={2185-94}}"}}, {"_id": "27706571", "pmid": 27706571, "title": "Effects of Shenkangling intervention on the MAPK pathway in rats with doxorubicin-induced nephropathy.", "journal": "Genet Mol Res", "authors": ["Ai S", "Lin YY", "Zheng J", "Qiu CX", "Liu YJ", "Lin X"], "date": "2016-08-19T00:00:00Z", "doi": "10.4238/gmr.15038131", "meta_date_publication": "2016 Aug 19", "meta_volume": "15", "meta_issue": "3", "meta_pages": "", "score": 50054.824, "text_hl": "The aim of this study was to investigate the effects of Shenkangling intervention on the mitogen-activated protein kinase (MAPK) pathway in @SPECIES_10116 @@@rats@@@ with @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@Adriamycin@@@-induced @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@nephropathy@@@ (@DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@AN@@@) and its underlying mechanism of action. @<m>DISEASE_Nephrosis</m> @DISEASE_MESH:D009401 @@@Nephrosis@@@ was induced in healthy Sprague-Dawley @SPECIES_10116 @@@rats@@@ by @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@doxorubicin@@@ and the @SPECIES_10116 @@@rats@@@ were untreated or treated with @CHEMICAL_Prednisone @CHEMICAL_MESH:D011241 @@@prednisone@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, Shenkangling, or a combination thereof. ", "citations": {"NLM": "Ai S, Lin YY, Zheng J, Qiu CX, Liu YJ, Lin X. Effects of Shenkangling intervention on the MAPK pathway in rats with doxorubicin-induced nephropathy. Genet Mol Res. 2016 Aug 19;15(3):. PMID: 27706571", "BibTeX": "@article{27706571, title={Effects of Shenkangling intervention on the MAPK pathway in rats with doxorubicin-induced nephropathy.}, author={Ai S and Lin YY and Zheng J and Qiu CX and Liu YJ and Lin X}, journal={Genet Mol Res}, volume={15}, number={3}}"}}]}